Poland· PL-100453187
Diuver
A torasemide product containing torasemidum, registered in Poland by Medezin Sp. z o.o.. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Torasemide is registered in 12 of 19 countries.
Countries holding a registration under ATC C03CA04 (torasemide), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Torasemide · ATC C03CA04
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Germany
- Ireland
- Italyprice
- Japan
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of torasemide costs, country by country.
Normalised to the WHO defined daily dose (15 mg), the median price runs from $0.28 in Italy to $0.58 in Switzerland — a ×2.1 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Torasemide · price per daily dose (15 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.58
- ES Spain$0.30
- IT Italy$0.28
The record
At a glance
URPL (Poland)- Active substance
- Torasemidum
- Manufacturer
- Medezin Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- C03CA04
- ATC class
- Torasemide
- Defined daily dose
- 15 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991455910
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
339 interactions on record for torasemide.
Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Torasemide · interactions on record
339 records
- 15 severe
- 214 moderate
- 10 minor
- 97 info
Most severe, free to view
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Torasemide in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainDILUTOL 5 mg COMPRIMIDOSViatris Healthcare Limited
- SwitzerlandTorasemid Mylan 5 mg, TablettenViatris Pharma GmbH
- United StatesTorsemideAvPAK
- United KingdomTorasemide 5mg tabletsKent Pharma (UK) Ltd
- CzechiaGROLANMenarini International Operations Luxembourg S.A., Luxembourg
- SwedenTorasemid Ebb 5 mg TablettEbb Medical AB
- IrelandTorasemide 5 mg TabletsAzure Pharmaceuticals Ltd.
- GermanyTorasemid 1 A Pharma1 A Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Torasemid Hexal
- Belgium · Torasemide Sandoz, Torrem
- Bulgaria · Toraflora, Диурестад
- Cyprus · Guperul
- Czechia · Torasemid Stada
- Germany · Torasemid 1 A Pharma, Torasemid Aaa
- Estonia · Torasemide, Torasemide Auxilia
- Spain · Dilutol, Dilutol Hta
- United Kingdom (Northern Ireland) · Torasemide, Torasemide Medreich
- Greece · Rosadim, Toresix
- Croatia · Diuver, Tomid
- Hungary · Tretax
- Ireland · Torasemide Azure Pharmaceuticals
- Italy · Diuremid, Diuresix
- Lithuania · Torasemide Auxilia, Torasemide Hexal
- Luxembourg · Torasemid Micro Labs, Torrem
- Latvia · Torasemide Hexal, Torasemide Polfarmex
- Sweden · Torasemid Zentiva, Torem
- Slovenia · Diuver
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f2fde798-6624-4871-9937-25c9be157438 GET /v1/drugs/f2fde798-6624-4871-9937-25c9be157438?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "5 mg",
"packaging": "05909991455910 ¦ Rp ¦ 140536\n30 tabl.",
"substance": "Torasemidum 5 mg",
"common_name": "Torasemidum",
"pl_product_id": "100453187",
"pozwolenie_nr": "204/21",
"auth_procedure": "IR",
"authorisation_validity": "2026-06-10"
}See everything about torasemide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.